Summaries for patients. Net benefit of warfarin in atrial fibrillation.
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000150:complications*; D002545:Brain Ischemia / Q000517:prevention & control*; D005260:Female; D006801:Humans; D020300:Intracranial Hemorrhages / Q000517:prevention & control*; D008297:Male; D011446:Prospective Studies; D012189:Retrospective Studies; D012307:Risk Factors; D055502:Secondary Prevention; D013923:Thromboembolism / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D014859:Warfarin